Chemotherapy may be recommended, as it can kill cancer cells around the body. Androgen deprivation therapy (ADT), or androgen suppression therapy, is a hormone #1 prostate supplement treatment that reduces the effect of androgen. Androgens are male hormones that can stimulate cancer growth. ADT #1 prostate supplement can slow down and even stop cancer growth by reducing androgen levels. The patient will likely need long-term hormone therapy. Even if the hormone therapy stops working after a while, there may be other options. Participation in clinical trials is one option that a patient may wish to discuss #1 prostate supplement with the doctor. Radical prostatectomy is not currently #1 prostate supplement an option for advanced cases, as it does #1 prostate supplement not treat the cancer that has spread to other parts of the body. Fertility As the prostate is directly involved with sexual reproduction, removing it affects semen production and fertility. Radiation therapy affects #1 prostate supplement the prostate tissue and often reduces the ability to father children. The sperm can be damaged and the semen insufficient for transporting sperm. Non-surgical options, too, can severely inhibit a man's reproductive capacity. Options for preserving these functions can include donating #1 prostate supplement to a sperm bank before surgery, or having sperm extracted directly from the testicles for artificial #1 Complications of prostate adenoma prostate supplement insemination into an egg. However, the success of these options is never guaranteed.
Patients with prostate cancer #1 prostate supplement can speak to a fertility doctor if they still intend to father children. This means that its fluids And secretions are intended for use outside of the body.
The prostate produces the fluid that nourishes and transports sperm on their journey to fuse with a female ovum, or egg, and produce human life. The prostate contracts and forces these fluids out during orgasm. The protein excreted #1 prostate supplement by the prostate, prostate-specific antigen (PSA), helps semen retain its liquid state.
An excess of this #1 prostate supplement protein in the blood is one of the first signs of prostate cancer. The urethra is tube through which sperm and urine exit the body. As such, the prostate is also responsible for urine control. It can tighten and restrict the flow of urine through the urethra using thousands of tiny muscle fibers. Tiny changes occur in the #1 prostate supplement shape and size of the prostate gland cells, known as prostatic intraepithelial neoplasia (PIN). This tends to happen slowly and does not show symptoms until further into the progression. Nearly 50 percent of all men over the age of 50 years have PIN.
High-grade PIN is considered pre-cancerous, and it requires further investigation. Prostate cancer can be successfully treated if it is diagnosed before metastasis, but if it spreads, it is more dangerous.
Stages Staging takes into account the size and extent of the tumor and the scale of the metastasis (whether it has traveled to other organs and #1 prostate supplement #1 prostate supplement tissues). At Stage 0, the tumor has neither spread #1 prostate supplement from the prostate gland nor invaded deeply into it. At Stage 4, the cancer has spread to distant sites and Prostate meme organs. Diagnosis A doctor will carry out a physical examination and enquire about any ongoing medical history. If the patient has #1 prostate supplement symptoms, or if a routine blood test shows abnormally high PSA levels, further examinations may be requested. Imaging scans can show and track the presence of prostate cancer.
Imaging scans can show and track the presence of prostate cancer.
Tests may include: a digital rectal examination (DRE), in which a doctor will manually check for any abnormalities of #1 prostate supplement the prostate with their finger a biomarker test #1 prostate supplement checking the blood, urine, or body tissues of a person with cancer for chemicals unique to individuals with cancer If these tests show abnormal results, further tests will include: a PCA3 test examining the urine for the PCA3 gene only found in prostate cancer cells a transrectal ultrasound scan providing imaging of the affected region using a probe that emits sounds a biopsy, or the removal of 12 to 14 small pieces of tissue #1 prostate supplement from several areas of the prostate for examination under a microscope These will help confirm the stage of the cancer, whether it has spread, and what treatment is appropriate.
To track any spread, or metastasis, doctors may use a bone, CT scan, #1 prostate supplement or MRI scan. Outlook If the disease is #1 prostate supplement found before it spreads to other organs in a process known as metastasis, the 5-year survival #1 Prostate supplement #1 prostate supplement rate is 99 percent.
Once the cancer metastasizes, or spreads, the 5-year survival rate is 29 percent. Regular screening can help detect prostate cancer while it is still treatable. Risk factors The exact #1 prostate supplement cause of prostate cancer is unclear, but there are #1 prostate supplement many possible risk factors.
Age Prostate cancer is rare among men under the age of 45 #1 prostate supplement #1 prostate supplement years, but more common after the age of 50 years. Geography Prostate cancer occurs most frequently in North America, northwestern Europe, on the Caribbean islands, and in Australia.
Genetic factors Certain genetic and #1 prostate supplement ethnic groups have an increased risk of prostate cancer.
Prostate lesion
Prostate 6.3
Prostate women
Prostate 2 finger breadth
| 30.07.2018 - Tarman |
| Response as measured by maximal intracavernosal pressure/mean arterial. |
| 30.07.2018 - SEMIMI_OQLAN |
| Prostate cancer are similar have higher PSA levels, while men who prostatic Hyperplasia Often. |
| 30.07.2018 - login |
| Some investigation into whether statins file that unclear, but there are many possible risk. |
| 30.07.2018 - Anar_sixaliyev |
| Physical examination and enquire (DRE): Because of where the prostate is located, the doctor inserts. |
| 30.07.2018 - Arxiles |
| More likely to be a sign of a very common. |
No comments:
Post a Comment